AAFACT

Brand name authorized in: Netherlands

Active ingredients

The drug AAFACT contains one active pharmaceutical ingredient (API):

1 Coagulation factor VIII
UNII 7PCM518YLR - EFMOROCTOCOG ALFA

Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X (factor Xa). Haemophilia A is a sex-linked hereditary disorder of blood coagulation due to decreased levels of factor VIII:C. By replacement therapy the plasma levels of factor VIII are increased, thereby enabling a temporary correction of the factor deficiency and correction of the bleeding tendencies.

Read about Coagulation factor VIII

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Coagulation factor VIII
B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
NL
Z-Index G-Standaard
Identifier(s): 13965255
NL
Z-Index G-Standaard, PRK
Identifier(s): 42730